Cargando…

Foreword: Acute optimization of heart rate in atrial fibrillation: landiolol as a first line therapy

Detalles Bibliográficos
Autor principal:	Dan, Gheorghe-Andrei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Acute optimization of heart rate in Atrial Fibrillation: Landiolol as a first line therapy Supplement Foreword
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9190748/ https://www.ncbi.nlm.nih.gov/pubmed/35706894 http://dx.doi.org/10.1093/eurheartjsupp/suac028

Ejemplares similares

Benefits and safety of landiolol for rapid rate control in patients with atrial tachyarrhythmias and acute decompensated heart failure
por: Shiga, Tsuyoshi
Publicado: (2022)

The role of landiolol in the management of atrial tachyarrhythmias in patients with acute heart failure and cardiogenic shock: case reports and review of literature
por: Bezati, Sofia, et al.
Publicado: (2022)

Landiolol for refractory tachyarrhythmias in the intensive care unit: case reports
por: Gangl, Clemens, et al.
Publicado: (2022)

Acute rate control in atrial fibrillation: an urgent need for the clinician
por: Dan, Gheorghe-Andrei, et al.
Publicado: (2022)

Short acting intravenous beta-blocker as a first line of treatment for atrial fibrillation after cardiac surgery: a prospective observational study
por: Chapalain, X, et al.
Publicado: (2022)

Ablation as First-line Therapy for Atrial Fibrillation
por: Andrade, Jason G
Publicado: (2023)

Atrial Fibrillation in Congenital Heart Disease
por: Martín de Miguel, Irene, et al.
Publicado: (2021)

Atrial fibrillation in cardiac resynchronization therapy
por: Elliott, Mark K., et al.
Publicado: (2021)

Neuromodulatory Approaches for Atrial Fibrillation Ablation
por: Rodríguez-Mañero, Moisés, et al.
Publicado: (2021)

Future Directions for Mapping Atrial Fibrillation
por: Zaman, Junaid AB, et al.
Publicado: (2022)

Pulsed Field Ablation for Atrial Fibrillation
por: Schaack, David, et al.
Publicado: (2023)

Artificial Intelligence for the Detection and Treatment of Atrial Fibrillation
por: Harmon, David M, et al.
Publicado: (2023)

Genetic risk and atrial fibrillation in patients with heart failure
por: Kloosterman, Mariëlle, et al.
Publicado: (2020)

Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation
por: Andrade, Jason G, et al.
Publicado: (2022)

Atrial fibrillation in heart failure: Prime time for ablation!
por: Deisenhofer, Isabel
Publicado: (2021)

Gut Microbiota and Atrial Fibrillation: Pathogenesis, Mechanisms and Therapies
por: Al-Kaisey, Ahmed M, et al.
Publicado: (2023)

Atrial fibrillation and 24‐h ambulatory blood pressure pattern
por: Verberk, Willem J.
Publicado: (2022)

Association Between Left Atrial Appendage Morphology and Function and the Risk of Ischaemic Stroke in Patients with Atrial Fibrillation
por: Dudziñska-Szczerba, Katarzyna, et al.
Publicado: (2022)

Considerations for the Assessment of Substrates, Genetics and Risk Factors in Patients with Atrial Fibrillation
por: Linz, Dominik, et al.
Publicado: (2021)

Atrial fibrillation is associated with increased central blood pressure and arterial stiffness
por: Pauklin, Priit, et al.
Publicado: (2021)

Mapping Technologies for Catheter Ablation of Atrial Fibrillation Beyond Pulmonary Vein Isolation
por: Rosa, Giulio La, et al.
Publicado: (2021)

Atrial fibrillation and heart failure: A contemporary review of current management approaches
por: Lee, Justin Z., et al.
Publicado: (2021)

Clinical Relevance of Sinus Rhythm Mapping to Quantify Electropathology Related to Atrial Fibrillation
por: van Schie, Mathijs S, et al.
Publicado: (2022)

Ambulatory blood pressure and risk of new‐onset atrial fibrillation in treated hypertensive patients
por: Coccina, Francesca, et al.
Publicado: (2020)

A Chronicle of Hybrid Atrial Fibrillation Ablation Therapy: From Cox Maze to Convergent
por: Kaba, Riyaz A, et al.
Publicado: (2022)

Management of Atrial Fibrillation Using Immunoglobulin Free Light Chains, Novel Biomarkers of Inflammation
por: Matsumori, Akira
Publicado: (2022)

Prevalence and prognosis of atrial fibrillation in a hypertensive population: A prospective cohort study
por: Wang, Chang, et al.
Publicado: (2023)

Heart failure with preserved ejection fraction: An alternative paradigm to explain the clinical implications of atrial fibrillation
por: Ariyaratnam, Jonathan P., et al.
Publicado: (2021)

Prevalence of atrial fibrillation and the risk of cardiovascular mortality among hypertensive elderly population in northeast China
por: Xia, Zhenwei, et al.
Publicado: (2022)

Safety, Efficacy and Prognostic Benefit of Atrial Fibrillation Ablation in Heart Failure with Preserved Ejection Fraction
por: Johner, Nicolas, et al.
Publicado: (2022)

Prediction of atrial fibrillation in patients with hypertension: A comprehensive comparison of office and ambulatory blood pressure measurements
por: Huang, Pin‐Hsiang, et al.
Publicado: (2022)

Ganglionic Plexus Ablation: A Step-by-step Guide for Electrophysiologists and Review of Modalities for Neuromodulation for the Management of Atrial Fibrillation
por: Aksu, Tolga, et al.
Publicado: (2023)

Percutaneous Left Atrial Appendage Occlusion: What the Practising Physician Should Know
por: Merella, Pierluigi, et al.
Publicado: (2023)

‘Pill-in-the-pocket’ Oral Anticoagulation Guided by Daily Rhythm Monitoring for Stroke Prevention in Patients with AF: A Systematic Review and Meta-analysis
por: Briosa e Gala, Andre, et al.
Publicado: (2023)

PITX2‐dependent gene regulation in atrial fibrillation and rhythm control
por: Syeda, Fahima, et al.
Publicado: (2017)

Foreword
por: Richards, M A
Publicado: (2008)

Foreword
por: Pépin, Michel, et al.
Publicado: (2010)

Foreword
por: Lars, Oreland
Publicado: (2010)

Foreword
por: Greenwood, DeLois
Publicado: (2009)

Foreword
por: Jiang, Zhenghua
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_164k113ga253oejhahknqj8hju